Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Activision Blizzard ( ATVI - Snapshot Report ) recently announced that it has collaborated with Bungie to develop a new first-person shooter game, Destiny. Destiny is a sci-fi story based game set in the very distant future. The game can be played on different platforms including Microsoft’s ( MSFT - Analyst Report ) Xbox 360, Sony’s PlayStation 3 and other console systems.
In the recently concluded quarter, Activision had announced that the company would invest in new IPs and join forces with Bungie to develop new games. Destiny is the first game of the collaboration between the two companies. Bungie has been associated with games such as Halo and other titles such as Marathon and Myth.
We believe that the current partnership with Bungie bodes well for the company’s long-term plans as Activision is desperately on the lookout for new titles. Activision has relied on Call of Duty, Skylanders, World of Warcraft and StarCraft franchises as the main source of revenues for the last couple of years. Activision has garnered solid revenues from the release of content packs and new versions of the franchise games. However, Call of Duty, World of Warcraft and StarCraft are all old franchises. Skylanders is a relatively new franchise and has done exceedingly well.
Thus, Activision’s effort to develop a new franchise to diversify its revenue source is a positive factor. However, the company remains cautious regarding fiscal 2013 given the volatile macroeconomic environment, uncertainty related to the console transition and tough year-over-year comparisons. Moreover, the company also provided a tepid outlook.
We also believe that the continued softness in the video game industry, limited presence in the mobile gaming segment, higher adoption of free-to-play games and significant competition from Electronic Arts ( EA - Analyst Report ) and Take-Two Interactive Software ( TTWO - Snapshot Report ) are the major headwinds for Activision going forward. Moreover, continued investments in new products are expected to hurt margins in the near term.
Currently, Activision Blizzard has a Zacks Rank #5 (Strong Sell).
Read the full Analyst Report on MSFT
Read the full Snapshot Report on ATVI
Read the full Snapshot Report on TTWO
Read the full Analyst Report on EA